During the past decade, Bay Area Cardiology Associates, P.A. conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bay Area Cardiology Associates, P.A." #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Amgen" with 3 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored and "United Therapeutics" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bay Area Cardiology Associates, P.A." #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Bay Area Cardiology Associates, P.A." are "Heart Failure" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "Atrial Fibrillation" (3 trials), "Coronary Artery Disease" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Bay Area Cardiology Associates, P.A." in a lesser frequency.

Most popular intervention types in "Bay Area Cardiology Associates, P.A." are "Drug" (10 trials), "Device" (9 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Oral treprostinil" (2 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials) and "Beraprost Sodium 314d Modified Release Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bay Area Cardiology Associates, P.A." are 26 trials for "All" genders.

Currently, there are NaN active trials in "Bay Area Cardiology Associates, P.A.". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Bay Area Cardiology Associates, P.A., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bay Area Cardiology Associates, P.A., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".